These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22285135)

  • 21. [How to slow the progression of chronic renal insufficiency].
    Rossert J; Ronco P
    Rev Prat; 2001 Feb; 51(4):378-84. PubMed ID: 11355601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and treatment of CKD.
    Ruggenenti P; Cravedi P; Remuzzi G
    J Am Soc Nephrol; 2012 Dec; 23(12):1917-28. PubMed ID: 23100218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Consensus document for the detection and management of chronic kidney disease].
    Martínez-Castelao A; Górriz JL; Bover J; Segura-de la Morena J; Cebollada J; Escalada J; Esmatjes E; Fácila L; Gamarra J; Gràcia S; Hernández-Moreno J; Llisterri-Caro JL; Mazón P; Montañés R; Morales-Olivas F; Muñoz-Torres M; de Pablos-Velasco P; de Santiago A; Sánchez-Celaya M; Suárez C; Tranche S
    Semergen; 2014; 40(8):441-59. PubMed ID: 25282133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of chronic kidney disease: can it be prevented or arrested?
    Jaber BL; Madias NE
    Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
    Cohen DL; Townsend RR
    J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complications of progression of CKD.
    Yang M; Fox CH; Vassalotti J; Choi M
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):400-5. PubMed ID: 22098657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing advanced chronic kidney disease: a primary care guide.
    Sakhuja A; Hyland J; Simon JF
    Cleve Clin J Med; 2014 May; 81(5):289-99. PubMed ID: 24789588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis PA; Ruilope LM
    Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.
    Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; Marcantoni C; de Jong PE; de Zeeuw D; Shahinfar S; Ruggenenti P; Remuzzi G; Levey AS;
    Kidney Int; 2001 Sep; 60(3):1131-40. PubMed ID: 11532109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of hypertension in CKD patients].
    Kusaba T; Kimura K
    Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Definition, diagnosis, grading and treatment of chronic kidney disease (CKD): an update].
    Kamata K
    Masui; 2013 Nov; 62(11):1284-92. PubMed ID: 24364269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of pre-dialysis care.
    Karkar A
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):419-27. PubMed ID: 21566294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What should be the goal blood pressure in nondiabetic chronic kidney disease?
    Schneider MP; Hilgers KF
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):180-5. PubMed ID: 24401787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.